Efficacy and Safety of SHR-1314 by Subcutaneous Injection in Active Moderate to Severe Graves' Orbitopathy Patients
Clinical trial NCT05394857 · TERMINATED
Trial details
- NCT number
- NCT05394857
- Sponsor
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-13
- Primary completion
- 2023-08-22
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.